Targeting ODC1 is currently being tested as a chemoprevention strategy in CRC, which, however, is associated with adenoma-carcinoma transformation [13,14,15] and not inflammation-induced carcinogenesis. The gene discussed is ODC1; the disease is colorectal carcinoma.